LG   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1947)

Organization Overview

First Clinical Trial
2003
NCT00600808
First Marketed Drug
2003
gemifloxacin (factive)
First NDA Approval
2003
gemifloxacin (factive)
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

LG Chem | LG CHEM LTD | LG Life Sciences